Doses of fluticasone propionate inhalation powder 50 and 100 mcg twice daily significantly improved FEV1 (15% and 18% change from baseline at Endpoint, respectively) compared with placebo (7% change).
Hosted on MSN1mon
Environmentally Friendlier COPD Inhaler May Also Be More EffectiveThe other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a. In a 2024 JAMA report ...
Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...
The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol inhalation powder – named VR 315 – will see Vectura receive $10 million for its part in the drug's ...
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate ... 500µg twice daily from a Diskus™ inhaler for a 4-week run-in period, dependent ...
It had been available as a prescription metered-dose inhaler (Flovent HFA) and a dry powder inhaler (Flovent Diskus). The switch to the identical generic version of both the metered dose and dry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback